Ameriprise
ACHV icon

Ameriprise’s Achieve Life Sciences ACHV Stock Holding History

Ameriprise’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Hold
0
– -$2K – 5799
2014
Q2 		– Sell
-1
Closed -$12.3K – 5195
2014
Q1 		$14K Buy
+1
New +$24.6K ﹤0.01% 4371
2013
Q4 		– Hold
0
– – – 4505
2013
Q3 		– Sell
-1
Closed -$20.7K – 5021
2013
Q2 		$17K Buy
+1
New +$22.4K ﹤0.01% 4385

Other funds holding ACHV

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Ameriprise's ACHV Position: Q3 2014 in Review

Ameriprise held its Achieve Life Sciences (ACHV) position steady in Q3 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5799.

Ameriprise first reported a position in ACHV in Q2 2013 and has held it in 2 quarters since. The position peaked at $17K in Q2 2013. 52 funds tracked by Wall St. Rank hold ACHV as of Q3 2014.

  • Ameriprise held 0 shares of Achieve Life Sciences worth $0 as of Q3 2014.
  • Ameriprise left its Achieve Life Sciences share count unchanged in Q3 2014.
  • Achieve Life Sciences made up ﹤0.01% of Ameriprise's portfolio in Q3 2014, its #5799 holding.
  • Ameriprise first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 2 quarters since.
  • Ameriprise's Achieve Life Sciences position peaked at $17K in Q2 2013.
  • 52 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2014.

Based on Ameriprise's 13F filing for Q3 2014, filed 14 Nov 2014.